Off-Label Use of Liraglutide in the Management of a Pediatric Patient with Type 2 Diabetes Mellitus

Off-Label Use of Liraglutide in the Management of a Pediatric Patient with Type 2 Diabetes Mellitus

Liraglutide is a glucagon-like peptide 1 (GLP-1) analog indicated for the treatment of type 2 diabetes mellitus as an adjunct to diet and exercise in adults. Liraglutide lowers blood glucose levels by stimulating insulin secretion and decreasing glucagon release in glucose-dependent manners, increas...

Full description

Saved in:

Bibliographic Details
Main Authors:	Sara J. Micale, Michael P. Kane, Eileen Hogan
Format:	Article
Language:	English
Published:	Wiley 2013-01-01
Series:	Case Reports in Pediatrics
Online Access:	http://dx.doi.org/10.1155/2013/703925
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Experience of the use of liraglutide (Victoza) in women with type 2 diabetes mellitus and obesity
by: Vladimir Ivanovich Kudinov, et al.
Published: (2011-06-01)

Efficacy of liraglutide in patients with metabolic-associated steatotic liver disease in type 2 diabetes mellitus
by: Yu.M. Stepanov, et al.
Published: (2025-06-01)

Impact of liraglutide on albumin-to-creatinine ratio in type 2 diabetes mellitus: a meta-analysis
by: Feng Wang, et al.
Published: (2025-07-01)

The Effect of Liraglutide on Epicardial Adipose Tissue in Type 2 Diabetes
by: Na Zhao, et al.
Published: (2021-01-01)

Estimating the budget impact of innovative pharmacological treatments for patients with type 2 diabetes mellitus in Italy: the case of liraglutide (GLP-1).
by: Stefano Capri, et al.
Published: (2015-06-01)

Effect of GLP-1 Receptor Agonists (Liraglutide) on Glycemic Parameters and Circulating miRNA Expression in Type 2 Diabetes Mellitus
by: Aqeel Meer AL-ZAMILY
Published: (2025-06-01)

Meta-analysis of the clinical efficacy of liraglutide in treating type 2 diabetes mellitus complicated with non-alcoholic fatty liver disease
by: Yuan-Yuan Xu, et al.
Published: (2024-09-01)

The Effect of Clinically Indicated Liraglutide on Pericoronary Adipose Tissue in Type 2 Diabetic Patients
by: Irmelin I. A. Biesenbach, et al.
Published: (2023-01-01)

The peculiarities of off-label use of drugs in pediatrics
by: S. M. Drohovoz, et al.
Published: (2020-10-01)

Liraglutide Treatment Reduces Endothelial Endoplasmic Reticulum Stress and Insulin Resistance in Patients With Diabetes Mellitus
by: Rosa Bretón‐Romero, et al.
Published: (2018-09-01)

Combined insulin detemir and liraglutide therapy in type 2 diabetic patients: a base for an alliance
by: Lyudmila Alexandrovna Ruyatkina, et al.
Published: (2017-06-01)

Race of GLPS: Impact on Weight and Glycemic Control on Type 2 Diabetes with Semaglutide Versus Liraglutide
by: Noha Hafeez, et al.
Published: (2024-12-01)

Prediction scale of response to liraglutide therapy as the method for increase of treatment efficacy in type 2 diabetes
by: Anna A Mosikian, et al.
Published: (2022-03-01)

Liraglutide use in pediatric type 2 familial partial lipodystrophy caused by LMNA mutation: a case report
by: Youran Li, et al.
Published: (2025-07-01)

Long-term effects of duodenal mucosal resurfacing and liraglutide on glycaemic control in patients with type 2 diabetes
by: Max Nieuwdorp, et al.

Off-Label Drug Use in Pediatric Practice: Unsolved Problems
by: A. R. Titova, et al.
Published: (2015-10-01)

Liraglutide, a Glucagon-Like Peptide-1 Analog, Increased Insulin Sensitivity Assessed by Hyperinsulinemic-Euglycemic Clamp Examination in Patients with Uncontrolled Type 2 Diabetes Mellitus
by: Hideaki Jinnouchi, et al.
Published: (2015-01-01)

LIRAGLUTIDE PLEIOTROPIC EFFECT IN CARDIOVASCULAR RISK REDUCTION IN TYPE 2 DIAbETES — A MANDATE FOR CARDIOLOGIST AND INTERNIST
by: S. V. Nedogoda
Published: (2018-05-01)

Compare the Decrease in Visceral Adipose Tissue in People with Obesity and Prediabetes vs. Obesity and Type 2 Diabetes Treated with Liraglutide
by: Rosa Nayely Hernández-Flandes, et al.
Published: (2025-07-01)

Assessment of mandatory declaration excipients in pediatric off label prescriptions in Spain
by: Irene Lizano-Díez, et al.
Published: (2025-07-01)

EXTENT OF UNLICENSED AND OFF-LABEL DRUG USE IN THE PEDIATRIC PRACTICE OF SMOLENSK
by: S.A. Rachina, et al.
Published: (2010-07-01)

Liraglutide for the treatment of obesity
by: Elmien Bronkhorst, et al.
Published: (2016-05-01)

The Cut-off Values of Triglycerides - Glucose Index for Metabolic Syndrome Associated with Type 2 Diabetes Mellitus
by: Ekhlas K. Hameed, et al.
Published: (2022-04-01)

Management of hypertension in patients with type 2 diabetes mellitus
by: M.L.I. Mashitisho
Published: (2013-02-01)

&ldquo;SGLT2 Inhibitor-Associated Diabetic Ketoacidosis in a Pediatric Patient: An Off- Label Use Case Report&rdquo;
by: Aldossari BF, et al.
Published: (2025-08-01)

Effects of Liraglutide Combined with Short-Term Continuous Subcutaneous Insulin Infusion on Glycemic Control and Beta Cell Function in Patients with Newly Diagnosed Type 2 Diabetes Mellitus: A Pilot Study
by: Weijian Ke, et al.
Published: (2016-01-01)

Diabetes Mellitus Type 2
by: Medical Schemes
Published: (2004-07-01)

Bridging the Gap: A Systematic Review with Expert Opinion on the Use of Dalbavancin for In-Label and Off-Label Indications in Pediatric Patients
by: Désirée Caselli, et al.
Published: (2025-01-01)

Pathophysiology and Management of Type 2 Diabetes Mellitus Bone Fragility
by: C. Eller-Vainicher, et al.
Published: (2020-01-01)

Management of type 2 diabetes mellitus at a rural hospital, Kwazulu-Natal, South Africa: Is the management of adult patients with type 2 diabetes mellitus optimal?
by: Rajan Govender, et al.
Published: (2009-04-01)

A Review of the Current State of Off‐Label Therapies for Pediatric Inflammatory Bowel Disease
by: Yassin EL‐Najjar, et al.
Published: (2025-06-01)

Effects of efpeglenatide versus liraglutide on gastric emptying, glucose metabolism and beta-cell function in people with type 2 diabetes: an exploratory, randomized phase Ib study
by: John Stewart, et al.
Published: (2021-03-01)

RETRACTED: Therapeutic efficacy of liraglutide on diabetic nephropathy mice by inhibiting inflammatory factors
by: WenXing Fan, et al.
Published: (2018-12-01)

The Potential Effect of Dapagliflozin and Liraglutide in Attenuating Cardio-Renal Injuries in Diabetic Rats
by: Albanna AA, et al.
Published: (2025-07-01)

Current state-of-the-art in the safe and efficient management of type 2 diabetes mellitusKey words: diabetes mellitus, vascular complications, glycemia control, management of diabetes mellitus
by: Alexander Sergeevich Ametov, et al.
Published: (2009-06-01)

Integrating psychotherapy and lifestyle interventions in the management of type 2 diabetes mellitus
by: Raluca-Anda Maier, et al.
Published: (2025-01-01)

Features of management and treatment of elderly patients with type 2 diabetes mellitus
by: L. Yu. Morgunov, et al.
Published: (2022-10-01)

Analysis of typical approaches to outpatient management of type 2 diabetes mellitus
by: Irina Evgen'evna Sapozhnikova, et al.
Published: (2012-09-01)

HYPERTENSION AND DIABETES MELLITUS TYPE 2
by: M. E. Statsenko, et al.
Published: (2018-05-01)

Type 2 diabetes mellitus and gout
by: O. V. Zhelyabina, et al.
Published: (2021-10-01)